Insights Into Bioventus Inc (BVS) Exposure By Institutions

After Hours

It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility.

Stocks Info

Bioventus Inc is listed on the NASDAQ in the Healthcare sector while operating in the Medical Devices industry. The current market capitalization of Bioventus Inc is $817.23M. A total of 1.07 million shares were traded on the day, compared to an average of 304.55K shares.

In the most recent transaction, Singleton Mark Leonard sold 6,498 shares of BVS for 10.19 per share on Feb 18 ’25. After the transaction, the SVP & CFO now owns 118,817 company shares. In a previous transaction on Feb 18 ’25, D’Adamio Anthony sold 4,380 shares at 10.19 per share. BVS shares that SVP & General Counsel owns now total 118,178.

Among the insiders who sold shares, CHURCH KATRINA J disposed of 1,537 shares on Feb 18 ’25 at a per-share price of $10.19. This resulted in the SVP & Chief Compliance Officer holding 50,102 shares of BVS after the transaction. In another insider transaction, Claypoole Robert E sold 28,786 shares at $9.10 per share on Jan 13 ’25. Company shares held by the President and CEO now total 64,964.

Despite rarely being accurate, price targets can exert some form of influence at times, and are often regarded as valuable by markets. In terms of 52-week highs and lows, BVS has a high of $14.38 and a low of $3.90.

Balance Sheet Annually/Quarterly

As well as showing the assets and liabilities of the company, the balance sheet also shows the amount invested in equity by investors. Investors can analyze a company’s future prospects by calculating its financial ratios based on this information. BVS’s latest balance sheet shows that the firm has $43.93M in Cash & Short Term Investments as of fiscal 2021. There were $357.68M in debt and $180.86M in liabilities at the time. Its Book Value Per Share was $2.28, while its Total Shareholder’s Equity was $533.79M.

Analysts Opinion

After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for BVS is Buy with a score of 4.33.

Most Popular

Related Posts